PCRX : Summary for Pacira Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets close in 2 hrs 30 mins

Pacira Pharmaceuticals, Inc. (PCRX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
50.45+6.75 (+15.45%)
As of 1:30PM EST. Market open.
People also watch
SUPNPTLACLVSIRWDPBYI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close43.70
Open56.65
Bid50.10 x 100
Ask50.20 x 200
Day's Range47.75 - 58.95
52 Week Range29.95 - 65.64
Volume4,964,890
Avg. Volume1,037,736
Market Cap1.89B
Beta2.25
PE Ratio (TTM)-50.91
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 24/7 Wall St.2 hours ago

    4 Biopharma Stocks Moving the Market on Wednesday

    These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to climb in the wake of the White House announcements.

  • TheStreet.com5 hours ago

    Pacira Pharmaceuticals Tops 4Q Earnings Expectations

    Pacira (PCRX) reported mixed fourth quarter results.

  • Associated Press6 hours ago

    Pacira reports 4Q loss

    On a per-share basis, the Parsippany, New Jersey-based company said it had a loss of 11 cents. Earnings, adjusted for one-time gains and costs, were 9 cents per share. The results surpassed Wall Street ...